B. Lange (Freiburg, Germany), L. Guglielmetti (Paris, France)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Relationship between active TB case finding and treatment outcomes
L. Rusakova (Moscow, Russian Federation), V. Galkin (St. Peterburg, Russian Federation), S. Sterlikov (Moscow, Russian Federation)
|   |
Prevalence of latent and active tuberculosis among elderly home residents in a single district of Sri Lanka- A cross sectional study
A. Bandara (Kilinochchi, Sri Lanka)
| |
Tuberculosis among health-care workers
E. Bogorodskaya (Moscow, Russian Federation), A. Markov (Moscow, Russian Federation), E. Belilovskiy (Moscow, Russian Federation)
| |
Pott’s disease : clinical ,radiological profil and therapeutic support
H. Arfaoui (casablanca, Morocco), H. Bamha (casablanca, Morocco), H. Jabri (casablanca, Morocco), W. El Khattabi (casablanca, Morocco), M. Afif (casablanca, Morocco)
| |
Transthyretin in patients with pulmonary tuberculosis co-infected HIV.
R. Abdullaev (Moscow, Russian Federation), O. Komissarova (Moscow, Russian Federation), L. Gerasimov (Moscow, Russian Federation)
| |
Predictive factors of extended drainage in tuberculous pneumothorax
S. Marwa (Tunis, Tunisia), B. Soumeya (Tunis, Tunisia), B. Amani (Tunis, Tunisia), G. Leila (Tunis, Tunisia), F. Soraya (Tunis, Tunisia), A. Hichem (Tunis, Tunisia), M. Adel (Tunis, Tunisia), H. Agnes (Tunis, Tunisia), C. Nawel (Tunis, Tunisia), D. Hafaoua (Tunis, Tunisia), T. Fatma (Tunis, Tunisia)
| |
Risk factors for tuberculosis in patients with chronic alcoholism
A. Ungurean (Chisinau, Republic of Moldova), E. Lesnic (Chisinau, Republic of Moldova), T. Osipov (Chisinau, Republic of Moldova), E. Cotelea (Chisinau, Republic of Moldova)
| |
Comparative study of clinical features between elderly and non-elderly patients with pulmonary nontuberculous mycobacterial disease
Y. Kobashi (Kurashiki (Okayama), Japan), D. Yoshioka (Kurashiki (Okayama), Japan), S. Kato (Kurashiki (Okayama), Japan), T. Oga (Kurashiki (Okayama), Japan)
| |
Nutritional deficiency in patients with pulmonary tuberculosis
M. Chushkin (Moscow, Russian Federation), V. Beketova (Moscow, Russian Federation), L. Popova (Moscow, Russian Federation), A. Egorova (Moscow, Russian Federation), V. Romanov (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
Particularities of people who inject drugs in a HIV-TB cohort
A. Zaharie (Bucharest, Romania), M. Tigau (Bucharest, Romania)
| |
Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants
E. Dementyeva (Moscow, Russian Federation), V. Aksenova (Moscow, Russian Federation), A. Kazakov (Moscow, Russian Federation), N. Klevno (Moscow, Russian Federation)
| |
Latent tuberculosis infection in adolescents aged 15-17
D. Vrabiy (Saint-Petersburg, Russian Federation), V. Dantsev (Saint-Petersburg, Russian Federation), I. Bozhkov (Saint-Petersburg, Russian Federation), G. Balasaniantc (Saint-Petersburg, Russian Federation)
| |
"99DOTS" techno-supervision for tuberculosis treatment – a boon or a bane? Exploring challenges in its implementation at a tertiary centre in Delhi, India
A. Prabhu (New Delhi (Delhi), India), U. Agarwal (New Delhi (Delhi), India), N. Singla (New Delhi (Delhi), India), R. Sarin (New Delhi (Delhi), India), J. Tripathy (New Delhi (Delhi), India), K. Sagili (New Delhi (Delhi), India), P. Thekkur (New Delhi (Delhi), India)
| |
The effect of tobacco smoking on bronchial patency in patients with pulmonary tuberculosis
A. Ergeshov (Moscow, Russian Federation), G. Sakharova (Moscow, Russian Federation), N. Antonov (Moscow, Russian Federation), L. Rusakova (Moscow, Russian Federation), V. Romanov (Moscow, Russian Federation), N. Chumovatov (Moscow, Russian Federation), M. Peredelskaya (Moscow, Russian Federation)
| |
PREDICTOR FACTORS TO POOR ADHERENCE TO ANTI-TUBERCULOSIS TREATMENT
H. Kchouk (Ariana, Tunisia), A. Ben Mansour (Ariana, Tunisia), S. Ben Saad (Ariana, Tunisia), H. Daghfous (Ariana, Tunisia), F. Tritar (Ariana, Tunisia)
| |
Screening and monitoring of TB infection in rheumatological patients on biologics therapy
S. Borisov (Moscow, Russian Federation), N. Makarova (Moscow, Russian Federation), L. Guntupova (Moscow, Russian Federation), K. Frolova (Moscow, Russian Federation), G. Lukina (Moscow, Russian Federation)
| |
New treatment outcome definitions for drug-susceptible and drug-resistant tuberculosis: update from World Health Organization
N. Nguyen (Genève, Switzerland), F. Mirzayev (Genève, Switzerland), K. Viney (Genève, Switzerland), M. Gegia (Genève, Switzerland), M. Zignol (Genève, Switzerland)
| |
A data-driven approach to identify putative tuberculosis among adolescents in resource-constrained settings.
S. Zhou (Rondebosch, South Africa), M. Orkin (Johannesburg, South Africa), E. Toska (Rondebosch, South Africa), R. Haghighat (Oxford, United Kingdom), W. Rudgard (Oxford, United Kingdom), Q. Van Staden (Rondebosch, South Africa), L. Cluver (Oxford, United Kingdom)
| |